Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with… Recruiting

2024-519344-32-00 Non-small Cell Lung Cancer 9 2026-03-16
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known t… Recruiting

2025-522613-26-00 Advanced Solid Cancers 7 2026-03-13
A Study of Evorpacept (ALX148) in Patients with Metastatic HER2-Positive Breast Cancer Recruiting

2025-522012-16-00 Breast Cancer 4 2026-03-13
Pasritamig With Docetaxel vs Docetaxel in Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting

2025-522713-29-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2026-03-12
Adjuvant radioligand therapy in neuroendocrine tumors Recruiting

2024-518236-36-00 Locoregionally restricted (stage III) small intestinal 5 2026-03-12
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lympho… Recruiting

2025-521205-41-00 Diffuse large B-cell lymphoma NOS, follicular lymphoma 4 2026-03-12
Neoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait A… Recruiting

2025-523692-39-00 locally advanced rectal cancer 5 2026-03-11
ROMANCE Recruiting

2025-521319-38-00 metastatic colorectal cancer 4 2026-03-11
A Study Testing a New Targeted Drug (TUB-040) in combination with Standard Chemotherapy for Women with Ovarian Cancer Recruiting

2025-524691-33-00 High-grade epithelial serous or endometrioid epithelial 9 2026-03-09
A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting

2024-516551-41-00 Patients with HER2-expressing solid tumors 4 2026-03-06
An open label phase II platform modular study exploring the efficacy and safety of the Valemetostat (EZH1/2 inhibitor) in patients with sele… Recruiting

2024-519788-16-00 Adult patients with histologically/cytologically confir 4 2026-03-05
FAPI-PET value for the initial screening of pancreatic and biliary cancers (FAPDIG Study) Recruiting

2024-517270-23-00 Cholangiocarcinoma 4 2026-03-05
Beamion LUNG-3: A study to test whether zongertinib helps people with surgically removed, non-small cell lung cancer with HER2 mutations com… Recruiting

2025-521284-12-00 Non-small cell lung cancer 5 2026-03-05
A clinical study to find the optimal dose of an investigational treatment called BNT323 when used in combination with another investigationa… Recruiting

2024-517979-20-00 Advanced Breast Cancer Metastatic Breast Cancer 9 2026-03-04
RUBIKID - Dynamic 82-Rb positron emission tomography (PET) for the grading of KIDney carcinoma Recruiting

2024-514085-39-00 Kidney carcinoma 4 2026-03-03
Total Neoadjuvant Treatment with or without Tislelizumab for Locally Advanced Rectal Cancer: An Open-label Randomized Controlled Phase II St… Recruiting

2025-522120-28-00 Locally Advanced Rectal Cancer (LARC) stage II (T3-4N0M 4 2026-03-03
Study aiming to compare the survival of patients with locally advanced or metastatic MSI/dMMR Esogastric adenocarcinomas treated by a combin… Recruiting

2023-506291-28-00 Patient with locally advanced/metastatic, MSI-H/dMMR ga 5 2026-03-02
Early-stage clinical trial investigating the individual and combined effect of two drugs, senicapoc and perampanel, as part of the treatment… Recruiting

2025-522605-37-00 Glioblastoma 3 2026-03-01
A trial to learn how safe AZD0486 is and how well it works in older or physically weak adults with large B-cell lymphoma when given after R-… Recruiting

2025-522029-37-00 Large B-cell Lymphoma 5 2026-02-27
Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs Recruiting

2025-523297-16-00 Non-Hodgkin Lymphoid Malignancies (NHLs) 1 2026-02-27
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants with Advanced Solid Tumors Previo… Recruiting

2025-521614-26-00 Advanced Solid Tumors 3 2026-02-26
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratum… Recruiting

2025-520897-21-00 Multiple Myeloma 10 2026-02-25
Radiopharmaceutical treatment of advanced kidney cancer Recruiting

2024-517899-38-00 Clear Cell Renal Cell Carcinoma (ccRCC) 4 2026-02-25
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24